Exact Mass: 528.2392910000001
Exact Mass Matches: 528.2392910000001
Found 500 metabolites which its exact mass value is equals to given mass value 528.2392910000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Satratoxin H
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside
Constituent of Phaseolus coccineus (scarlet runner bean) [DFC]. ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside is found in pulses. ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside is a constituent of Phaseolus coccineus (scarlet runner bean) [DFC]
16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside
16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated. 16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside is found in cereals and cereal products. 16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside is a constituent of rice (Oryza sativa) flower anthers. Constituent of rice (Oryza sativa) flower anthers. 16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside is found in cereals and cereal products.
Dutasteride
Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors, which block the action of the 5-alpha-reductase enzymes that convert testosterone into dihydrotestosterone (DHT). Finasteride also belongs to this group, but while dutasteride inhibits both isoforms of 5-alpha reductase, finasteride inhibits only one. Even so, a clinical study done by GlaxoSmithKline, the EPICS trial, did not find dutasteride to be more effective than finasteride in treating BPH. [Wikipedia] G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Felotaxel
Ibutamoren
Ret-P-man
Methyl 3beta-acetoxy-6-hydroxy-1-oxomeliac-14-enoate
2alpha-acetoxy-9alpha-benzoyloxy-5alpha,7beta,10beta,15-tetrahydroxy-11(15->1)-abeotaxa-4(20),11-dien-13-one|2??-Acetoxy-9??-benzoyloxy-5??,7??,10??,15-tetrahydroxy-11(15鈥樏傗垎1)-abeotaxa-4(20),11-dien-13-one
(?)-2-(Acetyloxy)-8-(furan-3-yl)dodecahydro-3,3,5,7a-tetramethyl-10,13-dioxo-1,5-methano-2H,8H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-4-acetic acid methyl ester
7-deacetyl-7-benzoyl-14,15-epoxyazadiradione|7-desacetyl-7-benzoylepoxyazadiradione
19-O-beta-D-Glucopyranoside-楼?脥2alpha楼?脫6alpha楼?脦-2,6,18,19-Tetrahydroxy-8,13-labdadien-15,16-olide
1alpha-O-(beta-D-glucopyranosyl)enmenol|1alpha-O-beta-D-glucopyranosylenmenol|ent-7beta,20-epoxykaur-16-ene-1beta,6alpha,7alpha,14alpha,15alpha-pentanol 1-O-beta-D-glucopyranoside
1,3,6,8-Tetramethyl-4,5-divinyl-9,10-dihydro-1,3-biphenanthrene-2,2,7,7-tetrol
3-Xyloside-(3beta,14beta)-3,14-Dihydroxy-19-oxobufa-5,7,20,22-tetraenolide
(3-Hydroxy-5-oxo-4-phenyl-5H-furan-2-ylidene)-phenylacetic Acid 6-hydroxy-1,7(11)-humuladienyl-10-yl ester
Dutasteride
G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Lurasidone HCl
Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively. Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is also a partial agonist of 5-HT1A receptor with an IC50 of 6.75 nM.
C25H36O12_2,7-Octadienoic acid, 6-hydroxy-2,6-dimethyl-, (1aR,1bS,2S,5aS,6R,6aS)-2-(beta-D-glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-5a-hydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-6-yl ester, (2E,6S)
[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate
methyl (2R)-2-(acetyloxy)-2-[(1S,3S,7R,8R,9R,12S,13R)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate
[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate_major
[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate_35.8\\%
Ala Glu Phe Tyr
Ala Glu Tyr Phe
Ala Phe Glu Tyr
Ala Phe Tyr Glu
Ala Ile Tyr Tyr
Ala Leu Tyr Tyr
Ala Tyr Glu Phe
Ala Tyr Phe Glu
Ala Tyr Ile Tyr
Ala Tyr Leu Tyr
Ala Tyr Tyr Ile
Cys Phe Phe Ile
Cys Phe Phe Leu
Cys Phe Ile Phe
Cys Phe Leu Phe
Cys His Asn Arg
Cys His Arg Asn
Cys Ile Phe Phe
Cys Leu Phe Phe
Cys Asn His Arg
Cys Asn Arg His
Cys Arg His Asn
Cys Arg Asn His
Asp Phe Phe Thr
Asp Phe Thr Phe
Asp Thr Phe Phe
Glu Ala Phe Tyr
Glu Ala Tyr Phe
Glu Phe Ala Tyr
Glu Phe Phe Ser
Glu Phe His Pro
Glu Phe Pro His
Glu Phe Ser Phe
Glu Phe Tyr Ala
Glu His Phe Pro
Glu His Ile Met
Glu His Leu Met
Glu His Met Ile
Glu His Met Leu
Glu His Pro Phe
Glu Ile His Met
Glu Ile Met His
Glu Leu His Met
Glu Leu Met His
Glu Met His Ile
Glu Met His Leu
Glu Met Ile His
Glu Met Leu His
Glu Pro Phe His
Glu Pro His Phe
Glu Ser Phe Phe
Glu Tyr Ala Phe
Glu Tyr Phe Ala
Phe Ala Glu Tyr
Phe Ala Tyr Glu
Phe Cys Phe Ile
Phe Cys Phe Leu
Phe Cys Ile Phe
Phe Cys Leu Phe
Phe Asp Phe Thr
Phe Asp Thr Phe
Phe Glu Ala Tyr
Phe Glu Phe Ser
Phe Glu His Pro
Phe Glu Pro His
Phe Glu Ser Phe
Phe Glu Tyr Ala
Phe Phe Cys Ile
Phe Phe Cys Leu
Phe Phe Asp Thr
Phe Phe Glu Ser
Phe Phe Ile Cys
Phe Phe Leu Cys
Phe Phe Ser Glu
Phe Phe Thr Asp
Phe His Glu Pro
Phe His Pro Glu
Phe Ile Cys Phe
Phe Ile Phe Cys
Phe Leu Cys Phe
Phe Leu Phe Cys
Phe Pro Glu His
Phe Pro His Glu
Phe Ser Glu Phe
Phe Ser Phe Glu
Phe Ser Leu Tyr
Phe Thr Asp Phe
Phe Thr Phe Asp
Phe Tyr Ala Glu
Phe Tyr Glu Ala
Phe Tyr Ser Ile
His Cys Asn Arg
His Cys Arg Asn
His Glu Phe Pro
His Glu Ile Met
His Glu Leu Met
His Glu Met Ile
His Glu Met Leu
His Glu Pro Phe
His Phe Glu Pro
His Phe Pro Glu
His His His Val
His His Val His
His Ile Glu Met
His Ile Met Glu
His Lys Met Asn
His Lys Asn Met
His Leu Glu Met
His Leu Met Glu
His Met Glu Ile
His Met Glu Leu
His Met Ile Glu
His Met Lys Asn
His Met Leu Glu
His Met Asn Lys
His Asn Cys Arg
His Asn Lys Met
His Asn Met Lys
His Asn Arg Cys
His Pro Glu Phe
His Pro Phe Glu
His Arg Cys Asn
His Arg Asn Cys
His Val His His
Ile Cys Phe Phe
Ile Glu His Met
Ile Glu Met His
Ile Phe Cys Phe
Ile Phe Phe Cys
Ile His Glu Met
Ile His Met Glu
Ile Met Glu His
Ile Met His Glu
Lys His Met Asn
Lys His Asn Met
Lys Met His Asn
Lys Met Asn His
Lys Asn His Met
Lys Asn Met His
Leu Cys Phe Phe
Leu Glu His Met
Leu Glu Met His
Leu Phe Cys Phe
Leu Phe Phe Cys
Leu His Glu Met
Leu His Met Glu
Leu Met Glu His
Leu Met His Glu
Met Glu His Ile
Met Glu His Leu
Met Glu Ile His
Met Glu Leu His
Met His Glu Ile
Met His Glu Leu
Met His Ile Glu
Met His Lys Asn
Met His Leu Glu
Met His Asn Lys
Met Ile Glu His
Met Ile His Glu
Met Lys His Asn
Met Lys Asn His
Met Leu Glu His
Met Leu His Glu
Met Asn His Lys
Met Asn Lys His
Asn Cys His Arg
Asn Cys Arg His
Asn His Cys Arg
Asn His Lys Met
Asn His Met Lys
Asn His Arg Cys
Asn Lys His Met
Asn Lys Met His
Asn Met His Lys
Asn Met Lys His
Asn Arg Cys His
Asn Arg His Cys
Pro Glu Phe His
Pro Glu His Phe
Pro Phe Glu His
Pro Phe His Glu
Pro His Glu Phe
Pro His Phe Glu
Pro Ser Tyr Tyr
Pro Tyr Ser Tyr
Pro Tyr Tyr Ser
Arg Cys His Asn
Arg Cys Asn His
Arg His Cys Asn
Arg His Asn Cys
Arg Asn Cys His
Arg Asn His Cys
Ser Glu Phe Phe
Ser Phe Glu Phe
Ser Phe Phe Glu
Ser Pro Tyr Tyr
Ser Tyr Phe Leu
Ser Tyr Ile Phe
Ser Tyr Leu Phe
Ser Tyr Pro Tyr
Ser Tyr Tyr Pro
Thr Asp Phe Phe
Thr Phe Asp Phe
Thr Phe Phe Asp
Thr Phe Val Tyr
Thr Phe Tyr Val
Thr Val Phe Tyr
Thr Val Tyr Phe
Thr Tyr Phe Val
Thr Tyr Val Phe
Val Phe Thr Tyr
Val Phe Tyr Thr
Val His His His
Val Thr Phe Tyr
Val Thr Tyr Phe
Val Tyr Phe Thr
Val Tyr Thr Phe
Tyr Ala Glu Phe
Tyr Ala Phe Glu
Tyr Ala Ile Tyr
Tyr Ala Leu Tyr
Tyr Ala Tyr Ile
Tyr Ala Tyr Leu
Tyr Glu Ala Phe
Tyr Glu Phe Ala
Tyr Phe Ala Glu
Tyr Phe Glu Ala
Tyr Phe Ile Ser
Tyr Phe Leu Ser
Tyr Phe Ser Ile
Tyr Phe Ser Leu
Tyr Phe Thr Val
Tyr Phe Val Thr
Tyr Ile Ala Tyr
Tyr Ile Phe Ser
Tyr Ile Ser Phe
Tyr Ile Tyr Ala
Tyr Leu Ala Tyr
Tyr Leu Phe Ser
Tyr Leu Ser Phe
Tyr Leu Tyr Ala
Tyr Pro Ser Tyr
Tyr Pro Tyr Ser
Tyr Ser Phe Ile
Tyr Ser Phe Leu
Tyr Ser Ile Phe
Tyr Ser Leu Phe
Tyr Ser Pro Tyr
Tyr Ser Tyr Pro
Tyr Thr Phe Val
Tyr Thr Val Phe
Tyr Val Phe Thr
Tyr Val Thr Phe
Tyr Tyr Ala Ile
Tyr Tyr Ala Leu
Tyr Tyr Ile Ala
Tyr Tyr Leu Ala
Tyr Tyr Pro Ser
Tyr Tyr Ser Pro
Coccinin
16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside
(1R,3S)-3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,(2R,3R)-2,3-dibenzoyloxybutanedioic acid
METHYL2,4-DIMETHYL-5-(TERT-BUTOXYCARBONYL)-3-PYRROLE PROPIONATE
(+)-4,5-Bis[hydroxy(diphenyl)methyl]-2-methyl-2-phenyl-1,3-dioxolane
Fentanyl citrate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)
1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide
Lurasidone Hydrochloride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively. Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is also a partial agonist of 5-HT1A receptor with an IC50 of 6.75 nM.
[(2S,3S,4S,6R)-6-[[(1S,3R,4R)-3-ethyl-3,4,10,12-tetrahydroxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-dimethylazanium
C28H34NO9+ (528.2233454000001)
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
7-Deacetyl-7-benzoylepoxyazadiradione
A limonoid that is epoxyazadiradione in which the acetyl group has been replaced by a benzoyl group. It has been isolated from Azadirachta indica.
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
(6R,11R,13R,14S,15S,21E,23S,27R)-27-hydroxy-23-[(1S)-1-hydroxyethyl]-9,15-dimethylspiro[4,12,17,24-tetraoxapentacyclo[21.3.1.113,16.06,11.06,15]octacosa-1,9,19,21-tetraene-14,2-oxirane]-3,18-dione
methyl (2R)-2-acetyloxy-2-[(1S,3S,7R,8R,9R,12S,13S)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
(1R,3aS,3bS,5aR,9aR,9bR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (Z)-tridec-9-enoate
(1E,6R,11R,13R,14S,15S,19E,21E,23S,27R)-27-hydroxy-23-[(1S)-1-hydroxyethyl]-9,15-dimethylspiro[4,12,17,24-tetraoxapentacyclo[21.3.1.113,16.06,11.06,15]octacosa-1,9,19,21-tetraene-14,2-oxirane]-3,18-dione
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
ent-6R,16bOH,17-Trihydroxy-7-oxo-6,7-seco-19,6-kauranolide 6-O-glucoside
16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside
4,5'-diethenyl-1',3,6',8-tetramethyl-9',10'-dihydro-[1,3'-biphenanthrene]-2,2',7,7'-tetrol
(1r,2s,3s,5s,7r,8s,9s,10s,11r,15s)-12,12-dimethyl-6-methylidene-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15-tetrol
6-hydroxy-2-methyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 6-hydroxy-2,6-dimethylocta-2,7-dienoate
3-(acetyloxy)-7-ethenyl-2,8a,9-trihydroxy-1,1,4a,7-tetramethyl-5,8-dioxo-octahydrophenanthren-4-yl benzoate
methyl (2r)-2-(acetyloxy)-2-[(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
(4ar,6s,7r,7as)-7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl (4s,5s,6s)-5-ethenyl-4-(2-hydroxyethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
methyl 2-[(1r,2r,5r,6r,13r,14s,16r)-14-(acetyloxy)-6-(furan-3-yl)-13-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
12,12-dimethyl-6-methylidene-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15-tetrol
(1'r,2s,3'r,8'r,12'e,15'r,17's,18's,25's,26's,28'r)-28'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24',29'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.1¹⁵,¹⁸.0³,⁸.0⁸,²⁶]nonacosane]-4',12',19',21'-tetraene-11',23'-dione
methyl 2-[(2s,3r,5r,6r,10s,13s,14r,16s)-3-(acetyloxy)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-16-yl]acetate
(3r,5s,7r,10r,12r,14s,15s,18r,19r,22s,23r)-10,22-dihydroxy-7,18-dimethyl-9-oxo-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-ene-14-carbaldehyde
methyl (1r,3s,6s,7s,10r,11r)-10-[(1r,6r)-6-[(acetyloxy)methyl]-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-6-(furan-3-yl)-7,11-dimethyl-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undecane-11-carboxylate
{2,6,6,14,19-pentamethyl-3,8,15,20-tetraoxo-7,16,18-trioxapentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosa-4,10-dien-11-yl}methyl 3-methylbutanoate
(1s,3r,7r,10s,13r,14s,18r,19r)-1-hydroxy-9,9,18-trimethyl-18-[(2s)-2-methyl-3-[(2z)-4-methyl-5-oxofuran-2-ylidene]propanoyl]-4,8,15-trioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁹]icosane-5,16-dione
methyl 2-[17-(acetyloxy)-9-(furan-3-yl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-15-yl]acetate
18'-(1-hydroxyethyl)-5',14',26'-trimethyl-2',7',11',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁹.0⁶,⁸.0⁹,²⁶]octacosane]-4',13',19',21'-tetraene-12',23'-dione
3-{4-[4-ethoxy-6-(2-methoxy-2-oxoethyl)-5,5,7-trimethyl-6,7-dihydro-4h-1-benzofuran-2-yl]-2-(furan-3-yl)-3-methyl-6-oxo-2h-pyran-3-yl}propanoic acid
methyl 2-[(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-17-(acetyloxy)-9-(furan-3-yl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-15-yl]acetate
2α-acetoxy-9α-benzoyloxy-5α,7β,10β,15-tetra-hydroxy-11(15→1)-abeotaxa-4(20),11-dien-13-one
{"Ingredient_id": "HBIN005268","Ingredient_name": "2\u03b1-acetoxy-9\u03b1-benzoyloxy-5\u03b1,7\u03b2,10\u03b2,15-tetra-hydroxy-11(15\u21921)-abeotaxa-4(20),11-dien-13-one","Alias": "NA","Ingredient_formula": "C29H36O9","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1=O)C(C)(C)O)OC(=O)C)O)O)C)OC(=O)C4=CC=CC=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "133","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3-hydroxy-5-oxo-4-phenyl-5h-furan-2-ylid-ene)-phenylaceticacid 6-hydroxy-1,7(11)-humuladienyl-10-yl ester
{"Ingredient_id": "HBIN008683","Ingredient_name": "(3-hydroxy-5-oxo-4-phenyl-5h-furan-2-ylid-ene)-phenylaceticacid 6-hydroxy-1,7(11)-humuladienyl-10-yl ester","Alias": "NA","Ingredient_formula": "C33H36O6","Ingredient_Smile": "CC1CCC(C(=C)CCC(C(C=C1)(C)C)OC(=O)C(=C2C(=C(C(=O)O2)C3=CC=CC=C3)O)C4=CC=CC=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10578","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-deacetylorthosiphol i
{"Ingredient_id": "HBIN009309","Ingredient_name": "3-o-deacetylorthosiphol i","Alias": "NA","Ingredient_formula": "C29H36O9","Ingredient_Smile": "CC(=O)OC1C(C(C2CC(C3(C(C2(C1OC(=O)C4=CC=CC=C4)C)C(=O)CC(C3=O)(C)C=C)O)O)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4759","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenostemmmoside d
{"Ingredient_id": "HBIN014699","Ingredient_name": "adenostemmmoside d","Alias": "NA","Ingredient_formula": "C26H40O11","Ingredient_Smile": "CC12CCCC(C1CCC34C2C(CC(C3)C(C4=O)(CO)O)O)(C)C(=O)OC5C(C(C(C(O5)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23668","TCMSP_id": "NA","TCM_ID_id": "7158","PubChem_id": "NA","DrugBank_id": "NA"}